Literature DB >> 23043934

Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia.

Lucia Magnolo1, Mohamed Najah, Tatiana Fancello, Enza Di Leo, Elisa Pinotti, Ines Brini, Neji M Gueddiche, Sebastiano Calandra, Naceur M Slimene, Patrizia Tarugi.   

Abstract

Monogenic hypobetalipoproteinemias include three disorders: abetalipoproteinemia (ABL) and chylomicron retention disease (CMRD) with recessive transmission and familial hypobetalipoproteinemia (FHBL) with dominant transmission. We investigated three unrelated Tunisian children born from consanguineous marriages, presenting hypobetalipoproteinemia associated with chronic diarrhea and retarded growth. Proband HBL-108 had a moderate hypobetalipoproteinemia, apparently transmitted as dominant trait, suggesting the diagnosis of FHBL. However, she had no mutations in FHBL candidate genes (APOB, PCSK9 and ANGPTL3). The analysis of MTTP gene was also negative, whereas SAR1B gene resequencing showed that the patient was homozygous for a novel mutation (c.184G>A), resulting in an amino acid substitution (p.Glu62Lys), located in a conserved region of Sar1b protein. In the HBL-103 and HBL-148 probands, the severity of hypobetalipoproteinemia and its recessive transmission suggested the diagnosis of ABL. The MTTP gene resequencing showed that probands HBL-103 and HBL-148 were homozygous for a nucleotide substitution in the donor splice site of intron 9 (c.1236+2T>G) and intron 16 (c.2342+1G>A) respectively. Both mutations were predicted in silico to abolish the function of the splice site. In vitro functional assay with splicing mutation reporter MTTP minigenes showed that the intron 9 mutation caused the skipping of exon 9, while the intron 16 mutation caused a partial retention of this intron in the mature mRNA. The predicted translation products of these mRNAs are non-functional truncated proteins. The diagnosis of ABL and CMRD should be considered in children born from consanguineous parents, presenting chronic diarrhea associated with hypobetalipoproteinemia.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043934     DOI: 10.1016/j.gene.2012.09.117

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

Review 1.  Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.

Authors:  Natasha Caminsky; Eliseos J Mucaki; Peter K Rogan
Journal:  F1000Res       Date:  2014-11-18

2.  The crystal structure of human microsomal triglyceride transfer protein.

Authors:  Ekaterina I Biterova; Michail N Isupov; Ronan M Keegan; Andrey A Lebedev; Anil A Sohail; Inam Liaqat; Heli I Alanen; Lloyd W Ruddock
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-08       Impact factor: 11.205

3.  SAR1B GTPase is necessary to protect intestinal cells from disorders of lipid homeostasis, oxidative stress, and inflammation.

Authors:  Alain Sané; Lena Ahmarani; Edgard Delvin; Nikolas Auclair; Schohraya Spahis; Emile Levy
Journal:  J Lipid Res       Date:  2019-08-13       Impact factor: 5.922

4.  Molecular characterization of Tunisian families with abetalipoproteinemia and identification of a novel mutation in MTTP gene.

Authors:  Mohamed Najah; Sarraj Mohamed Youssef; Hrira Mohamed Yahia; Slimani Afef; Jelassi Awatef; Hammami Saber; Najjar Mohamed Fadhel; Agnès Sassolas; Slimane Mohamed Naceur
Journal:  Diagn Pathol       Date:  2013-04-04       Impact factor: 2.644

5.  Chylomicron Retention Disease: a Description of a New Mutation in a Very Rare Disease.

Authors:  Helena Ferreira; Raquel Nuñez Ramos; Cinthia Flores Quan; Susana Redecillas Ferreiro; Vanessa Cabello Ruiz; Javi Juampérez Goñi; Jesus Quintero Bernabeu; Oscar Segarra Cantón; Marina Álvarez Beltran
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-04-13

6.  Knockdown of SAR1B suppresses proliferation and induces apoptosis of RKO colorectal cancer cells.

Authors:  Yong Lu; Shen-Kang Zhou; Rui Chen; Liang-Xian Jiang; Lei-Lei Yang; Tie-Nan Bi
Journal:  Oncol Lett       Date:  2020-09-03       Impact factor: 2.967

Review 7.  Current Diagnosis and Management of Abetalipoproteinemia.

Authors:  Manabu Takahashi; Hiroaki Okazaki; Ken Ohashi; Masatsune Ogura; Shun Ishibashi; Sachiko Okazaki; Satoshi Hirayama; Mika Hori; Kota Matsuki; Shinji Yokoyama; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-05-16       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.